Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences total assets
Total assets on the balance sheet at the end of each period.
Panacea Life Sciences's total assets was $17.41M at Mar 31, 2024. For fiscal 2023 it was $17.98M, down 7.7% from the year before. The highest annual figure on record is $31.36M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $17.98M | -7.7% |
| FY2022 | Dec 31, 2022 | $19.49M | -18.1% |
| FY2021 | Dec 31, 2021 | $23.78M | -24.2% |
| FY2020 | Dec 31, 2020 | $31.36M | +291.2% |
| FY2019 | Dec 31, 2019 | $8.02M | +56001.0% |
| FY2018 | Dec 31, 2018 | $14.29K | -91.7% |
| FY2017 | Dec 31, 2017 | $172.67K | -91.9% |
| FY2016 | Dec 31, 2016 | $2.13M | +2403.5% |
| FY2015 | Dec 31, 2015 | $84.89K | +0.1% |
| FY2014 | Dec 31, 2014 | $84.81K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | $17.41M | -6.2% |
| Q4 FY2023 | Dec 31, 2023 | $17.98M | -7.7% |
| Q3 FY2023 | Sep 30, 2023 | $18.73M | -6.3% |
| Q2 FY2023 | Jun 30, 2023 | $17.85M | -18.7% |
| Q1 FY2023 | Mar 31, 2023 | $18.56M | -17.2% |
| Q4 FY2022 | Dec 31, 2022 | $19.49M | -18.1% |
| Q3 FY2022 | Sep 30, 2022 | $19.98M | -17.3% |
| Q2 FY2022 | Jun 30, 2022 | $21.97M | -18.0% |
| Q1 FY2022 | Mar 31, 2022 | $22.41M | +38499.0% |
| Q4 FY2021 | Dec 31, 2021 | $23.78M | -24.2% |
| Q3 FY2021 | Sep 30, 2021 | $24.17M | +678.0% |
| Q2 FY2021 | Jun 30, 2021 | $26.78M | +344.1% |
| Q1 FY2021 | Mar 31, 2021 | $58.06K | -99.1% |
| Q4 FY2020 | Dec 31, 2020 | $31.36M | +291.2% |
| Q3 FY2020 | Sep 30, 2020 | $3.11M | -67.6% |
| Q2 FY2020 | Jun 30, 2020 | $6.03M | -6.2% |
| Q1 FY2020 | Mar 31, 2020 | $6.75M | +14.7% |
| Q4 FY2019 | Dec 31, 2019 | $8.02M | +56001.0% |
| Q3 FY2019 | Sep 30, 2019 | $9.59M | +73208.3% |
| Q2 FY2019 | Jun 30, 2019 | $6.43M | +7789.1% |
| Q1 FY2019 | Mar 31, 2019 | $5.89M | +6793.8% |
| Q4 FY2018 | Dec 31, 2018 | $14.29K | -91.7% |
| Q3 FY2018 | Sep 30, 2018 | $13.08K | -98.8% |
| Q2 FY2018 | Jun 30, 2018 | $81.45K | -92.5% |
| Q1 FY2018 | Mar 31, 2018 | $85.44K | -93.8% |
| Q4 FY2017 | Dec 31, 2017 | $172.67K | -91.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.05M | -2.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.09M | +0.3% |
| Q1 FY2017 | Mar 31, 2017 | $1.37M | +353.8% |
| Q4 FY2016 | Dec 31, 2016 | $2.13M | +2403.5% |
| Q3 FY2016 | Sep 30, 2016 | $1.08M | +3658.2% |
| Q2 FY2016 | Jun 30, 2016 | $1.09M | +1183.8% |
| Q1 FY2016 | Mar 31, 2016 | $302.09K | – |
| Q4 FY2015 | Dec 31, 2015 | $84.89K | – |
| Q3 FY2015 | Sep 30, 2015 | $28.86K | – |
| Q4 FY2014 | Dec 31, 2014 | $84.81K | – |
See a number that looks wrong?